Page last updated: 2024-10-30

meprobamate and Aphasia

meprobamate has been researched along with Aphasia in 2 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RENDI, L1
WEST, R1
STOCKEL, S1

Other Studies

2 other studies available for meprobamate and Aphasia

ArticleYear
[OUR EXPERIENCES WITH TRIOXAZIN AND ANDAXIN IN PHONIATRIC PRACTICE].
    Ful-, orr-, gegegyogyazat, 1963, Volume: 9

    Topics: Aphasia; Cleft Palate; Humans; Meprobamate; Morpholines; Speech Disorders; Stuttering

1963
THE EFFECT OF MEPROBAMATE ON RECOVERY FROM APHASIA.
    Journal of speech and hearing research, 1965, Volume: 8

    Topics: Aphasia; Biomedical Research; Drug Therapy; Intelligence Tests; Language; Meprobamate; Pharmacology;

1965